Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Migraine Parkinson's Disease Congress highlights Article Highlights from EAN 2022 — Day 1 — June 25th Alzheimer's Disease Congress highlights Article Neuroinflammation – why it matters in Alzheimer’s disease Bipolar Article Managing the burdens of bipolar disorder Schizophrenia Congress highlights Article “Schizophrenia: One disease or hundreds of diseases?”